Where innovation meets reliability in translational science
ABout us
Precision Engineered in vivo Models for Transformative Research
At Airmeith Bioscience, we make complex in vivo research simpler and faster. Our fully integrated platform takes your project from concept to high-quality data, supporting every stage of the study. We’re built for precision, efficiency, and real translational impact, helping you bring your assets closer to the clinic.
TESTIMONIALS
“Airmeith (previously TCD Transgenics) has supported several of our projects, including the development of a conditional FKBPL expression model. The team offered extensive expertise and close, one-to-one support, particularly during troubleshooting and project refinement. This level of technical expertise and engagement was central to the successful progression of our work on FKBPL.”
Professor Tracy Robson | Deputy Vice Chancellor Academic Affairs, RCSI University of Medicine and Health Sciences
“From the initial conception of the project, where we received advice on the exact mouse models needed, to the delivery of the models, the service we received from Airmeith (previously TCD Transgenics) was outstanding, especially given we had limited experience with generating and characterising KO mice. Through the service and support we received, we were able to make a significant contribution to clarifying the complex biology of SARM KO mice”
Professor Andrew Bowie, Professor of Innate Immunology, School of Biochemistry & Immunology TCD
“Airmeith (previously TCD Transgenics) were an outstanding partner in delivering a mouse model for a project I was advancing toward commercial funding. The single point mutant mouse strain was designed in collaboration with the team and was characterised to a very high standard. The resulting data played a pivotal role in securing a seed investment with a small consortium of investors which included a top-tier US-based life science VC firm”
William McCormack, CEO and Founder, Parvalis Tx
“For many years TCD Transgenics have supported our in vivo research, providing expert guidance on genetically altered models alongside high-quality cryopreservation and rederivation services. The team combines broad technical expertise with dependable, responsive support, and we have consistently experienced an excellent standard of service. Their depth of knowledge and reliability make them an important resource within the Irish research ecosystem, and their ongoing contribution will remain central to supporting the next generation of biomedical research in Ireland.”
Professor Luke O’Neill, Chair of Biochemistry, School of Biochemistry & Immunology TCD
“Our collaboration with the team at TCD Transgenics has spanned over five years, beginning with the ENACT DTIF project and most recently the PIONEER DTIF project. Their expertise in in vivo cancer models and collaborative, responsive approach have been instrumental in advancing our research into electroporation as a therapeutic strategy for colon cancer. We are delighted to continue our collaboration into the future.”
Declan Soden, Founder and CEO, Mirai Medical
PREVIOUS COLLABORATORS
OUR WORK
Scientific expertise and operational excellence
Our work has driven discovery – Our team develops advanced murine and cell line platforms and conducts in vivo studies across neurological, autoimmune, and oncology indications. These models enable target validation, mechanism-of-action studies, and preclinical efficacy testing, accelerating the path from discovery to clinical development. Explore some of our work here.
OUR SERVICES
Redefining how complex in vivo research is conducted
Our range of capabilities and services provide comprehensive research support. We specialise in the generation of genetically engineered and humanised disease models to support translational research. We offer services in in vitro investigation and preclinical in vivo disease models, along with full end-to-end project management, designed to de-risk and deliver the robust data you need.
Contact our team of scientific experts to discuss your project
We do this by offering a fully integrated, end-to-end platform for genetically altered model development. From concept to data, we provide a seamless solution that supports the entire lifecycle of your study—designed for precision, efficiency, and translational.
Send us an email
RESOURCES
Latest industry news, research, insights and learnings
Lorem ipsum dolor sit amet consectetur. Scelerisque in est egestas at turpis duis vulputate. Ut tempor ac nunc auctor viverra interdum nunc vestibulum enim. Ultrices nibh intege.